Sort
82,697 grants matching “vaccine development”
Preclinical Evaluation of Novel Adenovirus Vectors
$1,214,370Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
Acquisition of an Eclipse Tribrid Mass Spectometer System to Advance Proteomics Research in Rhode Island
$1,214,295Arthur Robert Salomon · Brown University · S10 · FY2024 · OD
Specific Pathogen Free 18 Baboon Research Resource {(SPF18BRR): Resource Core
$1,214,096Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2024 · OD
Specific Pathogen Free 18 Baboon Research Resource {(SPF18BRR): Resource Core
$1,214,094Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2023 · OD
Specific Pathogen Free 18 Baboon Research Resource {(SPF18BRR): Resource Core
$1,214,094William D Hopkins · University Of Tx Md Anderson Can Ctr · P40 · FY2025 · OD
Vaccine Production Core
$1,214,090Norman L Letvin · Duke University · U19 · FY2006 · AI
Vaccine Production Core
$1,214,090Duke University · U01 · FY2005 · AI
Allergen and T-Cell Reagent Resources for the Study of Allergic Diseases
$1,213,998Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2009 · AI
Herpesviruses as Vaccine Vectors for AIDS
$1,213,954David M Knipe · Harvard Medical School · P01 · FY2007 · AI
Development of novel inhibitors of C1q for the treatment of Neurodegenerative diseases
$1,213,915Ted Yednock · Annexon, Inc. · R44 · FY2016 · AG
Testing of Blood Samples for Immune Response and Vaccine Research
$1,213,840Richard A Koup · Niaid Extramural Activities · Z01 · FY2007 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,213,840Richard A Koup · Niaid Extramural Activities · Z01 · FY2007 · AI
Herpesviruses as Vaccine Vectors for AIDS
$1,213,797David M Knipe · Harvard Medical School · P01 · FY2006 · AI
Structure based design of trimer interface epitope focused universal influenza vaccines
$1,213,432James E Crowe · Vanderbilt University Medical Center · U01 · FY2023 · AI
NIH Tetramer Core Facility
$1,213,385John Altman · Emory University · N01 · FY2025 · AI
Response Therapies for MDR-TB
$1,213,289Ian M Orme · Colorado State University · U01 · FY2007 · AI
Malaria Drug Resistance and Disease Virulence
$1,213,263Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
$1,213,216Donald Bruce Edwards · Texas Biomedical Research Institute · U19 · FY2019 · AI
Prevention of Substance Use in At-risk Students: A Family-centered Web Program
$1,213,204Elizabeth A Stormshak · University Of Oregon · R01 · FY2021 · DA
Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa
$1,213,204Anavaj Sakuntabhai · Institut Pasteur · U01 · FY2021 · AI
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,212,678Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2015 · CA
Targeting CD180 to induce anti-KSHV response in nonhuman primates
$1,212,634Scott W Wong · Oregon Health & Science University · U01 · FY2024 · CA
PEDIATRIC AIDS CLINICAL TRIALS PROGRAM
$1,212,235Baylor College Of Medicine · U01 · FY2001 · AI
SMALL MOLECULE SCREENING TO IDENTIFY INHIBITORS OF FILOVIRAL
$1,212,185Arnab Basu · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Immune Reconstitution
$1,211,872Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA